Navigation path

News Highlights

5 April 2017

Katholieke Universiteit Leuven (KU Leuven) and partners developing dual vaccine against yellow fever and rabies, supported by Horizon 2020

The RABYD-VAX consortium, led by KU Leuven, is developing a cheap and easy-to-produce vaccine against rabies AND yellow fever which allows a stable temperature during transport and storage and thus guarantees a better efficiency compared to the existing vaccines.

3 April 2017

EMA publishes framework and action plan for closer interaction with academia

In the context of the European medicines regulatory network, the European Medicines Agency (EMA) has developed a framework and an action plan to reinforce collaboration with the academic community.

23 March 2017

ICPerMed Action Plan for Personalised Medicine published

The International Consortium for Personalised Medicine (ICPerMed), comprising over 30 European and international members, have published a consensus Action Plan on the research and development actions needed to further advance personalised medicine.

22 March 2017

Ebola vaccine immune responses of results obtained in EBOVAC1

EU-funded H2020 IMI research project on Ebola vaccine, EBOVAC1, induced durable immune response 1-year after vaccination.

21 March 2017

EU support the fight against tuberculosis: Reversion of antibiotic resistance in Mycobacterium tuberculosis

The newly identified molecule SMARt-420 has shown effective results in clearance promotion of multidrug-resistance strains of Mycobacterium tuberculosis from the lungs of mice.

The work received support from the European Research Council, Marie Skłodowska-Curie actions research fellowship and the EU collaborative research grant MM4TB.

20 March 2017

Health National Contact Points Network (Health NCP Net Project)

13 March 2017

Estimating the risk of microcephaly following Zika virus infection

The Horizon 2020 project ZIKAlliance published a study in the Bulletin of the World Health Organization, estimating the risk of microcephaly in women infected with Zika virus during pregnancy.

The study found that the risk varies substantially across Brazil, and was affected by different factors, such as the geographical area.

More News Headlines



Success Stories

Read more Success Stories

Upcoming Events

23-27 May 2017, Madrid, Spain - 35th Meeting of the European Society for Paediatric Infectious Diseases

29-30 May 2017, Vienna, Austria - euroPLX 64 Vienna Pharma Partnering

More Events

Social Corner


Facebook logo Find us on Facebook on the Innovation Union page